All Comments by John Trojanowski

  1. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
  2. Three weeks of running wheel exposure improves cognitive performance in the aged Tg2576 mouse.
  3. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
  4. Oligomeric alpha-synuclein inhibits tubulin polymerization.
  5. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.
  6. Alzheimer's researchers open the doors to data sharing.
  7. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.
  8. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
  9. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
  10. Chronic traumatic encephalopathy in a national football league player: part II.
  11. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
  12. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.
  13. CSF Biomarkers—Maybe You Can See the Forest for the Trees
  14. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
  15. 100 years and counting: prospects for defeating Alzheimer's disease.